India has significantly reduced medical visa approvals for Bangladeshis, creating an opportunity for China to expand its medical services in the country, according to a Reuters report. In 2023, a majority of Indian visas issued to Bangladeshis were for affordable private medical treatment. However, following Hasina’s ouster, India is now granting fewer than 1,000 medical visas per day, a steep decline from the previous 5,000–7,000 daily approvals. Meanwhile, at least 14 Chinese firms have invested over $230 million in Bangladesh since the interim government took office. India has yet to respond to Bangladesh’s extradition request regarding Hasina. The Chief Adviser is set to visit China later this month.